Journal of Shanghai Jiao Tong University (Medical Science) >

2023 , Vol. 43 >Issue 2: 171 - 179

DOI: https://doi.org/10.3969/j.issn.1674-8115.2023.02.005

Basic research

Improvement of alveolarization arrest in newborn rats with bronchopulmonary dysplasia via inhibiting alveolar epithelial cell pyroptosis

  • Xiaoyan ZHENG ,
  • Xingyun WANG ,
  • Yongjun ZHANG
Expand
  • 1.Department of Neonatology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China
    2.Hongqiao International Institute of Medicine, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200336, China
ZHANG Yongjun, E-mail: zhangyongjun@sjtu.edu.cn.

Received date: 2022-11-09

  Accepted date: 2023-02-06

  Online published: 2023-02-28

Fold

Abstract

Objective ·To study the effect of gasdermin D (GSDMD) inhibitor necrosulfonamide (NSA) on alveolarization arrest in lipopolysaccharide (LPS)-induced bronchopulmonary dysplasia (BPD) newborn rats via inhibiting alveolar epithelial cell pyroptosis. Methods ·Pregnant SD rats were randomly assigned to four groups as follows: control, BPD, BPD with NSA and NSA group, and then were prepared to receive intra-amniotic injection of LPS. Lung tissues of newborn rats on the first, third and seventh day after birth were stained by hematoxylin-eosin (H-E) to observe lung development. The expressions of GSDMD-N-terminal in lungs of newborn rats in each group were detected by immunofluorescence. The mRNA levels of interleukin-1β (IL-1β) of newborn rats' lungs was detected by real-time PCR. In vitro, the mouse alveolar epithelial cell line MLE-12 was cultured and treated with LPS/adenosine triphosphate (ATP) and NSA. The cell viability of MLE-12 cells was detected by CCK-8 method, the pyroptosis was detected by Hoechst 33342 and propidium iodide (PI) staining, and the expressions of surfactant protein C (SFTPC) and GSDMD-N protein in MLE-12 cells were detected by immunofluorescence. Results ·In vivo, intra-amniotic injection of LPS hindered lung development, resulting in the pathological hallmarks of BPD. The GSDMD-N expression of alveolar epithelial cells increased in the BPD rat model established by intra-amniotic injection of LPS, while NSA treatment significantly improved the lung development of BPD rats and inhibited the IL-1β mRNA expression (both P<0.05). In vitro, the study confirmed that LPS/ATP treatment decreased the viability of alveolar epithelial cells MLE-12 and induced pyroptosis, while NSA treatment increased alveolar epithelial cell viability and inhibited pyroptosis (both P<0.05). In addition, NSA treatment upregulated the SFTPC expression and inhibited the GSDMD-N expression in LPS/ATP-stimulated alveolar epithelial cells (both P<0.05). Conclusion ·Inhibiting the alveolar epithelial cell pyroptosis can improve the alveolar development in BPD newborn rats.

Key words： bronchopulmonary dysplasia; pyroptosis; gasdermin D (GSDMD); alveolar epithelial cell

Cite this article

Xiaoyan ZHENG , Xingyun WANG , Yongjun ZHANG . Improvement of alveolarization arrest in newborn rats with bronchopulmonary dysplasia via inhibiting alveolar epithelial cell pyroptosis[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023 , 43(2) : 171 -179 . DOI: 10.3969/j.issn.1674-8115.2023.02.005

References

1 THéBAUD B, GOSS K N, LAUGHON M, et al. Bronchopulmonary dysplasia [J]. Nat Rev Dis Primers, 2019, 5(1): 78.
2 STOLL B J, HANSEN N I, BELL E F, et al. Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993-2012[J]. JAMA, 2015, 314(10): 1039-1051.
3 BELL E F, HINTZ S R, HANSEN N I, et al. Mortality, in-hospital morbidity, care practices, and 2-year outcomes for extremely preterm infants in the US, 2013-2018[J]. JAMA, 2022, 327(3): 248-263.
4 ISLAM J Y, KELLER R L, ASCHNER J L, et al. Understanding the short- and long-term respiratory outcomes of prematurity and bronchopulmonary dysplasia[J]. Am J Respir Crit Care Med, 2015, 192(2): 134-156.
5 WILLIAMS E, GREENOUGH A. Advances in treating bronchopulmonary dysplasia[J]. Expert Rev Respir Med, 2019, 13(8): 727-735.
6 SHI J, GAO W, SHAO F. Pyroptosis: gasdermin-mediated programmed necrotic cell death[J]. Trends Biochem Sci, 2017, 42(4): 245-254.
7 JORGENSEN I, MIAO E A. Pyroptotic cell death defends against intracellular pathogens[J]. Immunol Rev, 2015, 265(1): 130-142.
8 LIAO J, KAPADIA V S, BROWN L S, et al. The NLRP3 inflammasome is critically involved in the development of bronchopulmonary dysplasia[J]. Nat Commun, 2015, 6: 8977.
9 DAPAAH-SIAKWAN F, ZAMBRANO R, LUO S, et al. Caspase-1 inhibition attenuates hyperoxia-induced lung and brain injury in neonatal mice[J]. Am J Respir Cell Mol Biol, 2019, 61(3): 341-354.
10 STOUCH A N, MCCOY A M, GREER R M, et al. IL-1β and inflammasome activity link inflammation to abnormal fetal airway development[J]. J Immunol, 2016, 196(8): 3411-3420.
11 KONG X, GAO M, LIU Y, et al. GSDMD-miR-223-NLRP3 axis involved in B(a)P-induced inflammatory injury of alveolar epithelial cells[J]. Ecotoxicol Environ Saf, 2022, 232: 113286.
12 WAN X P, LI J Q, WANG Y P, et al. H7N9 virus infection triggers lethal cytokine storm by activating gasdermin E-mediated pyroptosis of lung alveolar epithelial cells[J]. Natl Sci Rev, 2022, 9(1): nwab137.
13 HU J J, LIU X, XIA S, et al. FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation[J]. Nat Immunol, 2020, 21(7): 736-745.
14 RATHKEY J K, ZHAO J, LIU Z, et al. Chemical disruption of the pyroptotic pore-forming protein gasdermin D inhibits inflammatory cell death and sepsis[J]. Sci Immunol, 2018, 3(26): eaat2738.
15 KALIKKOT THEKKEVEEDU R, GUAMAN M C, SHIVANNA B. Bronchopulmonary dysplasia: a review of pathogenesis and pathophysiology[J]. Respir Med, 2017, 132: 170-177.
16 FRANK D, VINCE J E. Pyroptosis versus necroptosis: similarities, differences, and crosstalk[J]. Cell Death Differ, 2019, 26(1): 99-114.
17 ALI A, ZAMBRANO R, DUNCAN M R, et al. Hyperoxia-activated circulating extracellular vesicles induce lung and brain injury in neonatal rats[J]. Sci Rep, 2021, 11(1): 8791.
18 CAYABYAB R G, JONES C A, KWONG K Y, et al. Interleukin-1β in the bronchoalveolar lavage fluid of premature neonates: a marker for maternal chorioamnionitis and predictor of adverse neonatal outcome[J]. J Matern Fetal Neonatal Med, 2003, 14(3): 205-211.
19 ZHANG Q, RAN X, HE Y, et al. Acetate downregulates the activation of NLRP3 inflammasomes and attenuates lung injury in neonatal mice with bronchopulmonary dysplasia[J]. Front Pediatr, 2021, 8: 595157.
20 VAN OPDENBOSCH N, LAMKANFI M. Caspases in cell death, inflammation, and disease[J]. Immunity, 2019, 50(6): 1352-1364.
21 LU F, LAN Z, XIN Z, et al. Emerging insights into molecular mechanisms underlying pyroptosis and functions of inflammasomes in diseases[J]. J Cell Physiol, 2020, 235(4): 3207-3221.
22 DHANI S, ZHAO Y, ZHIVOTOVSKY B. A long way to go: caspase inhibitors in clinical use[J]. Cell Death Dis, 2021, 12(10): 949.
23 BIALER M, JOHANNESSEN S I, KUPFERBERG H J, et al. Progress report on new antiepileptic drugs: a summary of the Eleventh Eilat Conference (EILAT Ⅺ)[J]. Epilepsy Res, 2013, 103(1): 2-30.
24 FLORES J, NO?L A, FOVEAU B, et al. Pre-symptomatic caspase-1 inhibitor delays cognitive decline in a mouse model of Alzheimer disease and aging[J]. Nat Commun, 2020, 11(1): 4571.
25 HIRANI D, ALVIRA C M, DANOPOULOS S, et al. Macrophage-derived IL-6 trans-signalling as a novel target in the pathogenesis of bronchopulmonary dysplasia[J]. Eur Respir J, 2022, 59(2): 2002248.
26 HOU A, FU J, YANG H, et al. Hyperoxia stimulates the transdifferentiation of type Ⅱ alveolar epithelial cells in newborn rats[J]. Am J Physiol Lung Cell Mol Physiol, 2015, 308(9): L861-L872.
27 RACKLEY C R, STRIPP B R. Building and maintaining the epithelium of the lung[J]. J Clin Invest, 2012, 122(8): 2724-2730.
Options
Outlines

/

〈 〉